PLoS ONE 2012-01-01

A sulfhydryl-reactive ruthenium (II) complex and its conjugation to protein G as a universal reagent for fluorescent immunoassays.

Jing-Tang Lin, Po-Chung Chen, Thirumani Venkatshwar Goud, Bor-Rong Huang, Tzu-Chau Lin, Jean-François Biellmann, Chien-Sheng Chen

Index: PLoS ONE 7(4) , e36086, (2012)

Full Text: HTML

Abstract

To develop a fluorescent ruthenium complex for biosensing, we synthesized a novel sulfhydryl-reactive compound, 4-bromophenanthroline bis-2,2'-dipyridine Ruthenium bis (hexafluorophosphate). The synthesized Ru(II) complex was crosslinked with thiol-modified protein G to form a universal reagent for fluorescent immunoassays. The resulting Ru(II)-protein G conjugates were identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The emission peak wavelength of the Ru(II)-protein G conjugate was 602 nm at the excitation of 452 nm which is similar to the spectra of the Ru(II) complex, indicating that Ru(II)-protein G conjugates still remain the same fluorescence after conjugation. To test the usefulness of the conjugate for biosensing, immunoglobulin G (IgG) binding assay was conducted. The result showed that Ru(II)-protein G conjugates were capable of binding IgG and the more cross-linkers to modify protein G, the higher conjugation efficiency. To demonstrate the feasibility of Ru(II)-protein G conjugates for fluorescent immunoassays, the detection of recombinant histidine-tagged protein using the conjugates and anti-histidine antibody was developed. The results showed that the histidine-tagged protein was successfully detected with dose-response, indicating that Ru(II)-protein G conjugate is a useful universal fluorescent reagent for quantitative immunoassays.


Related Compounds

Related Articles:

Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine.

2015-01-29

[Vaccine 33(5) , 686-92, (2015)]

Tumor-targeted responsive nanoparticle-based systems for magnetic resonance imaging and therapy.

2014-12-01

[Pharm. Res. 31(12) , 3487-502, (2014)]

Self-assembled microbubbles as contrast agents for ultrasound/magnetic resonance dual-modality imaging.

2015-09-01

[Acta Biomater. 24 , 266-78, (2015)]

Use of antibody as carrier of oligomers of peptidomimetic alphavbeta3 antagonist to target tumor-induced neovasculature.

2007-01-01

[Bioconjug. Chem. 18(3) , 821-8, (2007)]

Studies of the influence of different cross-linking reagents on the immune response against a B-epitope.

1992-01-01

[Bioconjug. Chem. 3(1) , 80-4, (1992)]

More Articles...